Neuroscience
From The Times (UK):
The latest Parkinson’s treatment: Wii-hab
Parkinson’s disease symptoms could be controlled by a game that can be bought on every high street, says a recent study
Simon Crompton
21 September 2009
[snip]
This summer, the Medical College of Georgia in the United States announced the striking results of its research into the effects of “Wii-hab” on people with Parkinson’s disease. In an eight-week study, 18 people were asked to play Wii Sports, including virtual versions of boxing and ten-pin bowling, for an hour a day, three times a week for four weeks. By the end of that time all the participants showed significant improvements in rigidity, movement, fine motor skills and energy levels. Importantly, their depression levels also decreased; depression affects around half of people with Parkinson’s disease.
[snip}
Read the full article
- Parkinson's Disease: New Biomarker Effort
From the NIH: NIH launches collaborative effort to find biomarkers for Parkinson's New online resource will support data sharing NIH News 15 January 2013 [snip] "A new initiative aims to accelerate the search for biomarkers — changes in the body...
- Parkinson's Disease: Narrative From A Spouse
From The Times (UK): Case study: ‘It’s hard to recognise the man I married’ Judith Magill’s retirement dreams were dashed when her husband, Patrick, had Parkinson's disease diagnosed aged 57 21 September 2009 [snip] "People die with Parkinson’s...
- Acadia's Pimavanserin And Parkinson Disease Psychosis
FierceBiotech reported today about a failed Phase III trial of Acadia's Pimavanserin in a study of Parkinson's Disease Psychosis (sometimes abbreviated as "PDP"): ACADIA Pharmaceuticals Announces Results from Phase III Trial of Pimavanserin in...
- Rasagiline And Parkinson's Disease
From the FDA on the 17th of May: FDA Approves New Treatment for Parkinson's Disease The Food and Drug Administration today approved Azilect (rasagiline), a new molecular entity, for the treatment of Parkinson's disease. The drug is a monoamine...
- In The Weeklies
This week's issue of the New England Journal of Medicine (09 December 2004) includes two research papers and one editorial comment on topics concerning Parkinson disease: Levodopa and the Progression of Parkinson's Disease by The Parkinson...
Neuroscience
Parkinson's: Wii-hab and Symptom Improvement
From The Times (UK):
The latest Parkinson’s treatment: Wii-hab
Parkinson’s disease symptoms could be controlled by a game that can be bought on every high street, says a recent study
Simon Crompton
21 September 2009
[snip]
This summer, the Medical College of Georgia in the United States announced the striking results of its research into the effects of “Wii-hab” on people with Parkinson’s disease. In an eight-week study, 18 people were asked to play Wii Sports, including virtual versions of boxing and ten-pin bowling, for an hour a day, three times a week for four weeks. By the end of that time all the participants showed significant improvements in rigidity, movement, fine motor skills and energy levels. Importantly, their depression levels also decreased; depression affects around half of people with Parkinson’s disease.
[snip}
Read the full article
- Parkinson's Disease: New Biomarker Effort
From the NIH: NIH launches collaborative effort to find biomarkers for Parkinson's New online resource will support data sharing NIH News 15 January 2013 [snip] "A new initiative aims to accelerate the search for biomarkers — changes in the body...
- Parkinson's Disease: Narrative From A Spouse
From The Times (UK): Case study: ‘It’s hard to recognise the man I married’ Judith Magill’s retirement dreams were dashed when her husband, Patrick, had Parkinson's disease diagnosed aged 57 21 September 2009 [snip] "People die with Parkinson’s...
- Acadia's Pimavanserin And Parkinson Disease Psychosis
FierceBiotech reported today about a failed Phase III trial of Acadia's Pimavanserin in a study of Parkinson's Disease Psychosis (sometimes abbreviated as "PDP"): ACADIA Pharmaceuticals Announces Results from Phase III Trial of Pimavanserin in...
- Rasagiline And Parkinson's Disease
From the FDA on the 17th of May: FDA Approves New Treatment for Parkinson's Disease The Food and Drug Administration today approved Azilect (rasagiline), a new molecular entity, for the treatment of Parkinson's disease. The drug is a monoamine...
- In The Weeklies
This week's issue of the New England Journal of Medicine (09 December 2004) includes two research papers and one editorial comment on topics concerning Parkinson disease: Levodopa and the Progression of Parkinson's Disease by The Parkinson...